Park Joong-Min, Park Sung-Soo, Mok Young-Jae, Kim Chong-Suk
Department of Surgery, Korea University College of Medicine, Korea University Anam Hospital, 126-1 Anam-dong 5ga, Sungbuk-gu, Seoul 136-705, Korea.
Ann Surg Oncol. 2007 Sep;14(9):2535-42. doi: 10.1245/s10434-007-9445-1. Epub 2007 Jun 5.
Since the publication of the fifth edition of the UICC TNM classification, the rate of curative surgical resection for stage-IV gastric cancer has increased. It is related to the N3 category, which was the prior pN1 or pN2 in the fourth UICC TNM staging system and now pN3 in the fifth. We performed a retrospective analysis to determine whether the prognosis of N3M0 gastric cancer is different from that of other stage-IV gastric cancer; this may support sub-division of this disease.
We analyzed 422 patients with stage-IV gastric cancer who underwent gastric resection from 1983 to 2002 at Korea University Hospital. Clinical and pathological characteristics as well as survival of the patients were evaluated retrospectively according to the TNM categories.
The 5-year survival rate for those with N3M0 gastric cancer was 10.5%; this was influenced by depth of invasion (P = 0.001). According to the survival analysis in patients with stage-IV subtypes, the mean survival time was 25.6 months for T1-3N3M0, 24.7 months for T4N1-2M0, 10.0 months for T4N3M0, and 13.6 months for anyT anyNM1. Thus, the survival of patients with T4N3M0 and M1 stage disease was significantly shorter than that of patients with T1-3N3M0 and T4N1-2M0 stage disease (P = 0.000).
Sub-classification of stage-IV gastric cancer into IVa (T1-3N3M0, T4N1-2M0) and IVb (T4N3M0, anyT anyNM1) may be helpful to predict the outcome of patients with stage-IV gastric cancer.
自国际抗癌联盟(UICC)TNM分类第五版发布以来,IV期胃癌的根治性手术切除率有所提高。这与N3类别有关,在第四版UICC TNM分期系统中,它之前是pN1或pN2,而在第五版中现在是pN3。我们进行了一项回顾性分析,以确定N3M0期胃癌的预后是否与其他IV期胃癌不同;这可能支持对该疾病进行细分。
我们分析了1983年至2002年在韩国大学医院接受胃切除术的422例IV期胃癌患者。根据TNM分类对患者的临床和病理特征以及生存率进行回顾性评估。
N3M0期胃癌患者的5年生存率为10.5%;这受到浸润深度的影响(P = 0.001)。根据IV期亚型患者的生存分析,T1 - 3N3M0患者的平均生存时间为25.6个月,T4N1 - 2M0患者为24.7个月,T4N3M0患者为10.0个月,任何T任何NM1患者为13.6个月。因此,T4N3M0和M1期疾病患者的生存率明显低于T1 - 3N3M0和T4N1 - 2M0期疾病患者(P = 0.000)。
将IV期胃癌细分为IVa(T1 - 3N3M0,T4N1 - 2M0)和IVb(T4N3M0,任何T任何NM1)可能有助于预测IV期胃癌患者的预后。